Ikena Oncology (IKNA) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IKNA Stock Alerts $1.30 -0.01 (-0.76%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Ikena Oncology Short Interest DataCurrent Short Volume1,390,000 sharesPrevious Short Volume1,250,000 sharesChange Vs. Previous Month+11.20%Dollar Volume Sold Short$1.78 millionShort Interest Ratio / Days to Cover3.3Last Record DateApril 15, 2024Outstanding Shares48,260,000 sharesFloat Size25,380,000 sharesShort Percent of Float5.48%Today's Trading Volume122,140 sharesAverage Trading Volume364,166 sharesToday's Volume Vs. Average34% Short Selling Ikena Oncology ? Sign up to receive the latest short interest report for Ikena Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIKNA Short Interest Over TimeIKNA Days to Cover Over TimeIKNA Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Ikena Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,390,000 shares $1.78 million +11.2%5.5%3.3 $1.28 3/31/20241,250,000 shares $1.78 million +11.6%5.0%3.1 $1.42 3/15/20241,120,000 shares $1.76 million +15.0%4.5%2.9 $1.57 2/29/2024974,000 shares $1.39 million +47.0%3.9%2.8 $1.43 2/15/2024662,400 shares $967,104.00 +18.4%2.6%2.1 $1.46 1/31/2024559,400 shares $749,596.00 +30.5%2.0%2.1 $1.34 Get the Latest News and Ratings for IKNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ikena Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024428,700 shares $780,234.00 -9.3%1.5%2 $1.82 12/31/2023472,500 shares $930,825.00 +28.8%1.7%2.3 $1.97 12/15/2023367,000 shares $722,990.00 -60.9%1.3%1.8 $1.97 11/30/2023939,200 shares $1.36 million -8.8%3.6%5.2 $1.45 11/15/20231,030,000 shares $1.44 million -19.5%4.0%6 $1.40 10/31/20231,280,000 shares $5.16 million +1.6%4.1%14.3 $4.03 10/15/20231,260,000 shares $5.30 million +21.2%3.7%13.3 $4.21 9/30/20231,040,000 shares $4.50 million -1.0%3.8%11.4 $4.33 9/15/20231,050,000 shares $4.67 million +4.0%4.0%8.4 $4.45 8/31/20231,010,000 shares $4.69 million -3.8%4.3%8.1 $4.64 8/15/20231,050,000 shares $4.43 million +32.4%4.5%8.8 $4.22 7/31/2023793,000 shares $4.08 million +10.1%3.1%6.9 $5.15 7/15/2023720,400 shares $4.40 million +0.2%2.8%6.6 $6.11 6/30/2023719,100 shares $4.72 million +234.0%2.8%6.6 $6.56 6/15/2023215,300 shares $1.42 million -22.9%1.0%1.9 $6.60 5/31/2023279,400 shares $1.80 million -19.1%1.2%4 $6.45 5/15/2023345,200 shares $2.42 million -22.2%1.5%5.1 $7.00 4/30/2023443,700 shares $2.43 million -4.7%1.7%7 $5.48 4/15/2023465,600 shares $2.33 million +33.2%1.8%5.7 $5.00 3/31/2023349,500 shares $1.21 million +1.6%1.4%4.4 $3.45 3/15/2023344,000 shares $1.46 million +14.5%1.3%5.1 $4.25 2/28/2023300,400 shares $1.20 million -20.8%1.2%3.4 $4.01 2/15/2023379,400 shares $1.59 million -78.9%1.5%4.1 $4.20 1/31/20231,800,000 shares $7.67 million +6.5%9.3%16.6 $4.26 1/15/20231,690,000 shares $5.49 million +3.1%8.7%20.3 $3.25 12/30/20221,640,000 shares $4.36 million -3.0%8.4%19.4 $2.66 12/15/20221,690,000 shares $4.43 million -0.6%8.7%18.9 $2.62 11/30/20221,700,000 shares $3.79 million -0.6%8.7%16.7 $2.23 11/15/20221,710,000 shares $3.76 million +9.6%8.8%20 $2.20 10/31/20221,560,000 shares $4.29 million +1.3%6.0%21.5 $2.75 10/15/20221,540,000 shares $4.79 million -10.5%6.5%19.5 $3.11 9/30/20221,720,000 shares $6.11 million +3.0%7.2%17.1 $3.55 9/15/20221,670,000 shares $7.45 million +3.7%7.0%9.4 $4.46 8/31/20221,610,000 shares $7.65 million -5.3%6.8%7.4 $4.75Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> IKNA Short Interest - Frequently Asked Questions What is Ikena Oncology's current short interest? Short interest is the volume of Ikena Oncology shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,390,000 shares of IKNA short. 5.48% of Ikena Oncology's shares are currently sold short. Learn More on Ikena Oncology's current short interest. What is a good short interest ratio for Ikena Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IKNA shares currently have a short interest ratio of 3.0. Learn More on Ikena Oncology's short interest ratio. What is a good short interest percentage for Ikena Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.48% of Ikena Oncology's floating shares are currently sold short. Is Ikena Oncology's short interest increasing or decreasing? Ikena Oncology saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,390,000 shares, an increase of 11.2% from the previous total of 1,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ikena Oncology's float size? Ikena Oncology currently has issued a total of 48,260,000 shares. Some of Ikena Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ikena Oncology currently has a public float of 25,380,000 shares. How does Ikena Oncology's short interest compare to its competitors? 5.48% of Ikena Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Ikena Oncology: Genenta Science S.p.A. (0.02%), Entera Bio Ltd. (0.31%), Aligos Therapeutics, Inc. (0.87%), Instil Bio, Inc. (0.23%), Elutia Inc. (0.19%), Turnstone Biologics Corp. (4.76%), Precision BioSciences, Inc. (9.69%), Gritstone bio, Inc. (13.16%), Passage Bio, Inc. (4.24%), AVROBIO, Inc. (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Ikena Oncology stock? Short selling IKNA is an investing strategy that aims to generate trading profit from Ikena Oncology as its price is falling. IKNA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ikena Oncology? A short squeeze for Ikena Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IKNA, which in turn drives the price of the stock up even further. How often is Ikena Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IKNA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: GNTA Short Interest ENTX Short Interest ALGS Short Interest TIL Short Interest ELUT Short Interest TSBX Short Interest DTIL Short Interest GRTS Short Interest PASG Short Interest AVRO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IKNA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics